Primary site as a prognostic variable for children with pelvic soft tissue sarcomas

Area of Science:

• Pediatric Oncology
• Surgical Oncology
• Medical Oncology

Background:

• Soft tissue sarcomas are rare in children.
• Sarcomas can arise in the pelvis, bladder, or prostate.
• Treatment outcomes vary based on tumor location.

Purpose of the Study:

• To evaluate treatment outcomes for pediatric soft tissue sarcomas.
• To compare prognoses for sarcomas based on location (bladder-prostate vs. pelvis).
• To identify needs for improved treatment strategies.

Main Methods:

• Retrospective analysis of 16 pediatric patients (ages 1-16) treated between 1974-1983.
• Combination chemotherapy including vincristine, actinomycin D, cyclophosphamide, with optional doxorubicin, cis-platinum, and etoposide.
• Radiation therapy was administered to 13 patients; surgery (including cystectomy/prostatectomy) was performed as needed.

Main Results:

• 8 patients with bladder/prostate sarcomas (median size 5 cm) had better outcomes, with 6 disease-free survivors (1-9 years).
• 8 patients with pelvic sarcomas (median size 15 cm) had poorer outcomes, with only 3 disease-free survivors (1-8 years).
• Complete tumor excision was rarely achieved, especially for pelvic tumors.

Conclusions:

• Pediatric soft tissue sarcomas in the bladder-prostate region have a better prognosis than those in the retroperitoneum-pelvis.
• Early detection due to symptoms like urinary obstruction aids in better outcomes for bladder-prostate tumors.
• Improved treatment strategies are urgently needed for locally uncontrollable pelvic sarcomas.